American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Plexus Corp. (NASDAQ:PLXS) Forecasted to Earn Q3 2024 Earnings of $1.06 Per Share

Plexus Corp. (NASDAQ:PLXS) Forecasted to Earn Q3 2024 Earnings of $1.06 Per Share

Plexus Corp. (NASDAQ:PLXS – Free Report) – Equities researchers at Zacks Research dropped their Q3 2024 EPS estimates for Plexus in a note issued to investors on Wednesday, March 27th. Zacks Research analyst H. Sadavartia... More of this article »
Image about Antero Resources Co. (NYSE:AR) Forecasted to Post Q2 2024 Earnings of $0.03 Per Share

Antero Resources Co. (NYSE:AR) Forecasted to Post Q2 2024 Earnings of $0.03 Per Share

Antero Resources Co. (NYSE:AR – Free Report) – Investment analysts at Zacks Research upped their Q2 2024 earnings per share estimates for shares of Antero Resources in a report released on Tuesday, March 26th. Zacks... More of this article »
Image about Brokers Set Expectations for Contango Ore, Inc.’s Q2 2024 Earnings (NYSEAMERICAN:CTGO)

Brokers Set Expectations for Contango Ore, Inc.’s Q2 2024 Earnings (NYSEAMERICAN:CTGO)

Contango Ore, Inc. (NYSEAMERICAN:CTGO – Free Report) – Stock analysts at Roth Capital dropped their Q2 2024 earnings per share estimates for Contango Ore in a research note issued on Monday, March 25th. Roth Capital... More of this article »
Image about Wedbush Weighs in on SoFi Technologies, Inc.’s Q2 2024 Earnings (NASDAQ:SOFI)

Wedbush Weighs in on SoFi Technologies, Inc.’s Q2 2024 Earnings (NASDAQ:SOFI)

SoFi Technologies, Inc. (NASDAQ:SOFI – Free Report) – Research analysts at Wedbush lifted their Q2 2024 earnings per share (EPS) estimates for SoFi Technologies in a report issued on Wednesday, March 27th. Wedbush analyst... More of this article »
Image about Equities Analysts Offer Predictions for Axsome Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:AXSM)

Equities Analysts Offer Predictions for Axsome Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:AXSM)

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Research analysts at HC Wainwright reduced their Q2 2024 EPS estimates for shares of Axsome Therapeutics in a research note issued to investors on Tuesday, March... More of this article »
Image about Seaport Res Ptn Research Analysts Increase Earnings Estimates for The Walt Disney Company (NYSE:DIS)

Seaport Res Ptn Research Analysts Increase Earnings Estimates for The Walt Disney Company (NYSE:DIS)

The Walt Disney Company (NYSE:DIS – Free Report) – Analysts at Seaport Res Ptn boosted their Q2 2024 EPS estimates for Walt Disney in a report released on Tuesday, March 26th. Seaport Res Ptn analyst D. Joyce now forecasts... More of this article »
Image about Roth Capital Comments on Invesco S&P Emerging Markets Low Volatility Index ETF’s Q3 2024 Earnings (TSE:ELV)

Roth Capital Comments on Invesco S&P Emerging Markets Low Volatility Index ETF’s Q3 2024 Earnings (TSE:ELV)

Invesco S&P Emerging Markets Low Volatility Index ETF (TSE:ELV – Free Report) – Analysts at Roth Capital lowered their Q3 2024 earnings per share (EPS) estimates for Invesco S&P Emerging Markets Low Volatility... More of this article »
Image about Q2 2024 Earnings Estimate for Terex Co. (NYSE:TEX) Issued By Zacks Research

Q2 2024 Earnings Estimate for Terex Co. (NYSE:TEX) Issued By Zacks Research

Terex Co. (NYSE:TEX – Free Report) – Equities research analysts at Zacks Research upped their Q2 2024 EPS estimates for shares of Terex in a research report issued on Wednesday, March 27th. Zacks Research analyst M.... More of this article »
Image about Q2 2024 EPS Estimates for Nuvation Bio Inc. (NYSE:NUVB) Raised by Analyst

Q2 2024 EPS Estimates for Nuvation Bio Inc. (NYSE:NUVB) Raised by Analyst

Nuvation Bio Inc. (NYSE:NUVB – Free Report) – Research analysts at Wedbush raised their Q2 2024 EPS estimates for Nuvation Bio in a report released on Monday, March 25th. Wedbush analyst D. Nierengarten now expects... More of this article »
Image about Q2 2024 EPS Estimates for First Foundation Inc. Decreased by Analyst (NASDAQ:FFWM)

Q2 2024 EPS Estimates for First Foundation Inc. Decreased by Analyst (NASDAQ:FFWM)

First Foundation Inc. (NASDAQ:FFWM – Free Report) – Investment analysts at Wedbush cut their Q2 2024 earnings per share estimates for shares of First Foundation in a research note issued on Wednesday, March 27th. Wedbush... More of this article »
Image about Reviewing LanzaTech Global (LNZA) & The Competition

Reviewing LanzaTech Global (LNZA) & The Competition

LanzaTech Global (NASDAQ:LNZA – Get Free Report) is one of 44 publicly-traded companies in the “Industrial organic chemicals” industry, but how does it compare to its peers? We will compare LanzaTech Global to related... More of this article »
Image about Red River Bancshares (NASDAQ:RRBI) and Triumph Financial (NASDAQ:TFIN) Head to Head Comparison

Red River Bancshares (NASDAQ:RRBI) and Triumph Financial (NASDAQ:TFIN) Head to Head Comparison

Red River Bancshares (NASDAQ:RRBI – Get Free Report) and Triumph Financial (NASDAQ:TFIN – Get Free Report) are both small-cap finance companies, but which is the better business? We will compare the two companies based... More of this article »
Image about Comparing InterRent Real Estate Investment Trust (OTCMKTS:IIPZF) & Centerspace (NYSE:CSR)

Comparing InterRent Real Estate Investment Trust (OTCMKTS:IIPZF) & Centerspace (NYSE:CSR)

Centerspace (NYSE:CSR – Get Free Report) and InterRent Real Estate Investment Trust (OTCMKTS:IIPZF – Get Free Report) are both small-cap finance companies, but which is the superior investment? We will compare the two companies... More of this article »
Image about Financial Survey: Electriq Power (NYSE:ELIQ) and Energizer (NYSE:ENR)

Financial Survey: Electriq Power (NYSE:ELIQ) and Energizer (NYSE:ENR)

Energizer (NYSE:ENR – Get Free Report) and Electriq Power (NYSE:ELIQ – Get Free Report) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their... More of this article »
Image about Comparing ImmunityBio (IBRX) & Its Competitors

Comparing ImmunityBio (IBRX) & Its Competitors

ImmunityBio (NASDAQ:IBRX – Get Free Report) is one of 281 public companies in the “Biological products, except diagnostic” industry, but how does it compare to its competitors? We will compare ImmunityBio to similar... More of this article »